Pay in 4 interest-free payments of $25.71 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
05 nM) and an EC90 equal to 9
and decreased the immature forms
Odanacatib also shows weak inhibition of the processing of the MHC II invariant chain protein Iip10 in mouse splenocytes compared to LHVS (minimum inhibitory concentration 1-10 μM versus 0
Formula: C20H21FN6O5
35(8):1074-81
PF-04217903 (methanesulfonate) medil Hydrochloride 05 nM) and an EC90PF 04217903 is a MET tyrosine kinase inhibitor, is also a n orally bioavailabe, small molecule tyrosine kinase inhibitor of the proto oncogene c Met (hepatocyte growth factor receptor [HGFR]) with potential antineoplastic activity. c Met inhibitor PF 04217903 selectively binds to and inhibits c Met, disrupting the c Met signaling pathway, which may result in the inhibition of tumor cell growth, migration and invasion of tumor cells, and the induction
US$ 23100.00
US$ 2800.00
US$ 24750.00
US$ 39600.00
US$ 12495.00
US$ 22000.00
US$ 44000.00
US$ 34100.00
US$ 4995.00
US$ 11250.00